Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Clinical Oncology Next Generation Sequencing Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the clinical oncology next generation sequencing market has expanded quickly over the recent years. Its growth is projected to continue from $0.51 billion in 2024 to $0.58 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%. The escalations experienced in the historical period can be linked to the advancements in genomic research, the discovery of cancer biomarkers, technological progress, and regulatory approvals.

The size of the clinical oncology next generation sequencing market is projected to experience swift expansion in the ensuing years. By 2029, it’s estimated to increase to $0.94 billion, with a compound annual growth rate (CAGR) of 12.7%. This predicted growth during the forecast period can be related to the rising occurrence of cancer, precision medicine, immuno-oncology, and liquid biopsies. Key trends during this forecast period encompass comprehensive genomic profiling (cgp), immuno-oncology, tumor variation and diversity, as well as artificial intelligence and machine learning.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Clinical Oncology Next Generation Sequencing Market?

The global increase in cancer cases is projected to spur the expansion of the clinical oncology next-generation sequencing market within the forecast period. For example, the National Cancer Institute, a Government agency based in the United States, recorded approximately 18.1 million cancer survivors in the country as of May 2024. This number is anticipated to climb to 22.5 million by 2032. It’s forecasted that by 2040, the annual count of new cancer cases will reach 29.9 million, while the anticipated cancer-related deaths will escalate to 15.3 million. Consequently, the rising global cancer incidence rate is expected to stimulate the demand and growth of the clinical oncology next-generation sequencing market.

Which Primary Segments of the Clinical Oncology Next Generation Sequencing Market Are Driving Growth and Industry Transformations?

The clinical oncology next generation sequencingmarket covered in this report is segmented –

1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing

2) By Application: Screening, Companion Diagnostics, Other Diagnostics

3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories

Subsegments:

1) By Ion Semiconductor Sequencing: Ion Proton System, Ion PGM System, Ion S5 System, Other Ion Semiconductor Sequencing Technologies

2) By Pyro-Sequencing: 454 Pyrosequencing, Other Pyro-Sequencing Technologies

3) By Synthesis Sequencing: Illumina Sequencing Technology, SOLiD Sequencing Technology, Other Synthesis Sequencing Technologies

4) By Real-Time Sequencing: PacBio RS II System, Sequel System, Other Real-Time Sequencing Technologies

5) By Ligation Sequencing: Helicos Single Molecule Sequencing, Other Ligation Sequencing Technologies

6) By Reversible Dye Termination Sequencing: Illumina HiSeq, Illumina NextSeq, Other Reversible Dye Termination Sequencing Technologies

7) By Nano-Pore Sequencing: Oxford Nanopore Technologies (MinION, GridION, PromethION), Other Nano-Pore Sequencing Technologies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3344&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Clinical Oncology Next Generation Sequencing Market?# Market?

North America was the largest region in the clinical oncology next-generation sequencing market in 2024. Asia-Pacific was the second largest region in the clinical oncology next-generation sequencing market. The regions covered in the clinical oncology next generation sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Clinical Oncology Next Generation Sequencing Market?

Leading businesses in the clinical oncology next-generation sequencing market, such as Roche, are introducing revolutionary new products like the BenchMark ULTRA PLUS system. These innovations not only increase their market profitability but also prove invaluable to clinical labs engaged in cancer diagnostics and research. BenchMark ULTRA PLUS assures precise and efficient diagnostic testing, ultimately leading to enhanced patient care. In June 2022, Switzerland’s pharmaceutical giant, Roche introduced this state-of-the-art platform for tissue staining. This system aids clinicians in determining a patient’s treatment course expediently by providing quick and precise test results.

View the full report here:

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

What Parameters Are Used to Define the Clinical Oncology Next Generation Sequencing Market?

Next generation sequencing (NGS) is a process used to determine the sequence of nucleotides in a section of DNA and is used in oncology research. NGS is used to identify rare cancer mutations and familial cancer mutation carriers and to provide molecular rationale for appropriate targeted therapy.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3344

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model